Free Continuing Education
Learn at your own pace anywhere and anytime with these free CE accredited modules
Learn at your own pace anywhere and anytime with these free CE accredited modules
Transfusion-transmitted infections (TTI) persist despite interventions used to reduce risk. This series of continuing education learning modules will review how blood safety is changing and methodologies to identify and mitigate the risks associated with blood product transfusions.
• Recognize the incidence of bacterial contamination of platelets for transfusion
• Understand the clinical presentation and consequences of infections from contaminated blood products
• Describe approaches for mitigation of bacterial contamination of blood products, especially platelets, for
transfusion
• Identify the signs and symptoms of a transfusion-transmitted bacterial infection and review follow-up actions
• Recognize the definition and understand the history of emerging pathogens.
• Describe the factors that drive the spread of emerging pathogens.
• Understand the risks emerging pathogens pose to the blood supply.
• Describe methods to prevent emerging pathogens from entering the blood supply.
• Learn about the advancement of hemorrhage control and the MTP
• Discuss the importance of fibrinogen and what makes a healthy clot
• Assess early replacement of fibrinogen in bleeding patients
• Differentiate Cryoprecipitate AHF, Fibrinogen Concentrates, and Pathogen Reduced Cryoprecipitate
Fibrinogen Complex
• Analyze studies focusing on cryoprecipitate use and fibrinogen replacement
• Describe the underlying cause and approaches for addressing Transfusion-Associated
Graft-Versus-Host Disease (TA-GVHD)
• Discuss the AABB Standards for Blood Banks and Transfusion Services (BBTS) that address approaches for
lowering the risk of or preventing
TA-GVHD.
• Understand the two options authorized by the AABB Standards for prevention of TA-GVHD: irradiation and
psoralen/UVA light treatment (pathogen
reduction) of platelets.
• Define the mechanisms of action of the available methods for pathogen reduction for platelets and plasma.
• Discuss the safety parameters of the available methods for pathogen reduction for platelets and plasma.
• Review the clinical, in vitro, and hemovigilance data for pathogen reduction.
• Summarize the data concerning the use of pathogen reduction in both adult and pediatric populations.
Earn Professional Acknowledgment for Continuing Education P.A.C.E. credits.
Earn California Board of Registered Nursing (CBRN) Continuing Education credits.
